In 2016, the EpiPen became a symbol of the drug-pricing problem in the US.

Over a decade, the price for a two-pack has gone up from $93.88 to $608.61, an increase of more than 500%. On Thursday, the FDA approved Teva’s generic version of the drug, dealing a blow to branded EpiPen-maker Mylan.

The injectable device delivers a dose of epinephrine, otherwise known as adrenaline, to treat extreme allergic reactions.

Read more


Related Articles